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Abstract Patients with chronic small bowel obstruction and malignant ascites from diffuse peritoneal carcinomatosis
have limited options for gastrointestinal decompression as part of end-of-life palliation. Insertion of a percutaneous
gastrostomy tube is relatively contraindicated in patients with ascites. Alternatively, nasogastric tube placement often
leads to significant discomfort to patients and necessitates hospitalization during their last days of life. Here, we
demonstrate how placing a percutaneous cervical esophago-gastric tube can allow adequate gastrointestinal decompres-
sion for terminal patients with malignant small bowel obstruction. This palliative measure allows them to remain in the
comfort of their own homes after the procedure.
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Introduction
Malignant small bowel obstruction (MSBO) is a common
diagnosis in patients with advanced stage malignancies.1
Bypass surgery is the standard surgical palliative treat-
ment for these patients; however, palliative surgery in
these terminal patients is often not well-tolerated.1,2 In
these patients, palliative decompression of MSBO to
avoid intractable vomiting is necessary. While these pa-
tients are admitted, nasogastric tubes (NGTs) are often
placed for immediate decompression of the stomach.
However, NGTs are poorly tolerated as they cause sig-
nificant discomfort to patients and may even cause sinus-
itis and pressure ulcers of the nasal septum.3 In addition,
NGTs commit most patients to spend their last few days
of life in the hospital since discharging them home risks
dislodgement of the tube. Therefore, percutaneous endo-
scopic gastrostomy (PEG) tube has been advocated for
gastrointestinal decompression to allow end-of-life care
and palliation at home.2 However, often times in patients
with MSBO and diffuse peritoneal carcinomatosis, the
presence of ascites makes PEG placement technically
difficult, as ascites fluid limits the degree of transillumi-
nation through the stomach, impairs maturation of the
fibrous tract along the PEG tube,4 and sets the patient
up for intraperitoneal contamination as well as persistent
ascites leakage from the PEG tube site.4 Although large-
volume paracentesis prior to PEG tube insertion and at
intervals thereafter may reduce the likelihood of
peristomal ascitic fluid leakage,2 ascites have been
viewed as a relative contraindication to PEG placement.5
In an effort to allow end-of-life care at home for patients
with ascites associated with MSBO, over the last 2 years we
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have successfully placed three percutaneous palliative cervical
esophago-gastric tubes in terminal patients to decompress
their gastrointestinal tract.
Technique
The procedure is performed under general anesthesia in a
supine position in the operating room. The patients’ neck
is turned to the right and their left neck is prepped and
draped in a routine sterile fashion. With or without ultra-
sound guidance (operator preference), a 21-gauge intro-
ducer needle from a Micropuncture® Introducer Set
(Cook Medical, Bloomington, IN) is inserted following a
track anterior to the sternocleidomastoid muscle (Fig. 1).
During the insertion, suction is applied onto the needle to
prevent any injury to major vessels in the neck. Intubation
of needle into the esophagus is confirmed with simulta-
neous endoscopy. With the needle in the esophagus, the
guidewire from the Micropuncture® Introducer Set is then
threaded down under endoscopic guidance. The introduc-
er needle is then removed and the tract is dilated with a 5
Fr dilator from the Introducer set. The wire is removed,
and the Amplatz Super StiffTM wire (Boston Scientific,
Marlborough, MA) is passed distally into the esophageal
lumen. The dilator is withdrawn, and a 22 Fr dilator with
a peel-away sheath (Kimberly-Clark, Roswell, GA) is
then used to dilate the tract after enlarging the neck inci-
sion. The Amplatz Super StiffTM wire and dilator are re-
moved, leaving the peel-away sheath in place. An 18 Fr
NGT is then threaded through the sheath, which is then
separated leaving the NGT in place. The enteric tube is
guided into the proximal stomach under endoscopic visu-
alization, and is anchored to the neck at approximately
40 cm using 2–0 silk sutures (Fig. 2). Two stay sutures
are placed along the patient’s left side of the neck to
anchor the tube without tension.
Discussion
Despite the common occurrence of MSBO in patients with
advanced stage cancer, there has not been any significant im-
provement in its prevention or management.1 Because the
majority of available treatments are futile at this stage of dis-
ease, improving quality of life for such terminal patients is of
utmost importance. Currently utilized NG and PEG tubes as a
palliative measure are less than optimal methods for these
patients. Therefore, we have successfully employed a novel
technique as described here in three patients with MSBO and
malignant ascites from diffuse peritoneal carcinomatosis. One
of our patients with metastatic rectal cancer developed a skin
abscess around the cervical esophago-gastric tube on postop-
erative day 2 that resolved by postoperative day 7 with a
counter-incision and drainage at the bedside and antibiotics.
It was felt that the abscess occurred as the patient was on
concurrent chemotherapy and thus immunosuppressed. In
the other two patients (with metastatic gastric cancer and co-
lon cancer), there were no procedure-related complications,
and all of them did well. All of our patients were discharged
homewithin 2 weeks after the procedure with no re-admission
to the hospital. The patient’s fluid shifts and pain were man-
aged at home under the care of a hospice team.
Based on our experience, we feel that surgeons can easily
adopt this technique. Cervical esophago-gastric decompression
is well-tolerated by patients and is easily managed by their fam-
ilies. Therefore, we advocate the use of cervical esophago-
gastric decompression in terminal patients with MSBO for pal-
liation, which can allow them to be home for hospice care.
Fig. 1 Landmark of needle puncture site, anterior to the sternocleidomastoid
muscle in left cervical region about two fingerbreadths above the
sternoclavicular joint (blackarrow)
Fig. 2 Final image of percutaneous cervical esophago-gastric tube
placement along with radiographic image
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